A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Clinical trial NCT05211323 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05211323
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Combined Hepatocellular Carcinoma and Cholangiocarcinoma Stage III Liver Cancer Stage IV Liver Cancer

Start date: 2022-12-07
Primary completion: 2026-01-20
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.